Linked Life Data

15738531

Source:http://linkedlifedata.com/resource/pubmed/id/15738531

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
15
pubmed:dateCreated
2005-5-23
pubmed:abstractText
To evaluate docetaxel in the treatment of patients with early-stage prostate cancer with prostate-specific antigen (PSA) progression after local therapy without androgen ablation therapy.
pubmed:grant
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0732-183X
pubmed:author
pubmed:issnType
Print
pubmed:day
20
pubmed:volume
23
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
3352-7
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:15738531-Adenocarcinoma, pubmed-meshheading:15738531-Adult, pubmed-meshheading:15738531-Aged, pubmed-meshheading:15738531-Antineoplastic Agents, Hormonal, pubmed-meshheading:15738531-Dose-Response Relationship, Drug, pubmed-meshheading:15738531-Drug Administration Schedule, pubmed-meshheading:15738531-Humans, pubmed-meshheading:15738531-Male, pubmed-meshheading:15738531-Maximum Tolerated Dose, pubmed-meshheading:15738531-Middle Aged, pubmed-meshheading:15738531-Neoadjuvant Therapy, pubmed-meshheading:15738531-Neoplasm Staging, pubmed-meshheading:15738531-Neoplasms, Hormone-Dependent, pubmed-meshheading:15738531-Prognosis, pubmed-meshheading:15738531-Prostate-Specific Antigen, pubmed-meshheading:15738531-Prostatic Neoplasms, pubmed-meshheading:15738531-Risk Assessment, pubmed-meshheading:15738531-Survival Rate, pubmed-meshheading:15738531-Taxoids, pubmed-meshheading:15738531-Treatment Outcome
pubmed:year
2005
pubmed:articleTitle
Effect of docetaxel in patients with hormone-dependent prostate-specific antigen progression after local therapy for prostate cancer.
pubmed:affiliation
Department of Medicine, University of Medicine and Dentistry of New Jersey/Robert Wood Johnson Medical School, Piscataway, USA.
pubmed:publicationType
Journal Article, Clinical Trial, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't, Clinical Trial, Phase III, Research Support, N.I.H., Extramural